US4609643A
(en)
*
|
1980-08-06 |
1986-09-02 |
Aktiebolaget Hassle |
Renin inhibitors, treatments and dipeptide synthesis
|
US4650661A
(en)
*
|
1982-09-15 |
1987-03-17 |
Aktiebolaget Hassle |
Enzyme inhibitors
|
EP0104041B1
(en)
*
|
1982-09-15 |
1988-07-27 |
Aktiebolaget Hässle |
Enzyme inhibitors
|
US4595677A
(en)
*
|
1982-12-03 |
1986-06-17 |
Ciba-Geigy Corporation |
Substituted tetrapeptides
|
GB2135773B
(en)
*
|
1983-01-31 |
1985-12-04 |
Boots Celltech Diagnostics |
Enzyme inhibitor labelled immunoassay
|
GB8322414D0
(en)
*
|
1983-08-19 |
1983-09-21 |
Szelke M |
Renin inhibitors
|
AU573735B2
(en)
*
|
1983-02-07 |
1988-06-23 |
Aktiebolaget Hassle |
Peptide analogue enzyme inhibitors
|
GB8305985D0
(en)
*
|
1983-03-04 |
1983-04-07 |
Szelke M |
Enzyme inhibition
|
IT1164239B
(it)
*
|
1983-05-25 |
1987-04-08 |
Anic Spa |
Un retro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica
|
US4613676A
(en)
*
|
1983-11-23 |
1986-09-23 |
Ciba-Geigy Corporation |
Substituted 5-amino-4-hydroxyvaleryl derivatives
|
EP0144290A3
(de)
*
|
1983-12-01 |
1987-05-27 |
Ciba-Geigy Ag |
Substituierte Aethylendiaminderivate
|
JPS60163899A
(ja)
*
|
1984-02-03 |
1985-08-26 |
Sankyo Co Ltd |
レニン阻害ペプチド類
|
CA1254699A
(en)
*
|
1984-03-12 |
1989-05-23 |
Jasjit S. Bindra |
Renin inhibitors containing statine or derivatives thereof
|
US4661473A
(en)
*
|
1984-03-27 |
1987-04-28 |
Merck & Co., Inc. |
Renin inhibitors containing peptide isosteres
|
EP0156318A3
(en)
*
|
1984-03-27 |
1988-07-06 |
Merck & Co. Inc. |
C-terminal amide cyclic renin inhibitors containing peptide isosteres
|
US4668663A
(en)
*
|
1984-03-27 |
1987-05-26 |
Merck & Co., Inc. |
Renin inhibitors containing homophe8
|
US4663310A
(en)
*
|
1984-04-04 |
1987-05-05 |
Merck & Co., Inc. |
Renin inhibitors containing 2-substituted statine
|
EP0163237A3
(en)
*
|
1984-05-29 |
1988-04-27 |
Merck & Co. Inc. |
Di- and tri-peptidal renin inhibitors
|
US4645759A
(en)
*
|
1984-06-22 |
1987-02-24 |
Abbott Laboratories |
Renin inhibiting compounds
|
US4652551A
(en)
*
|
1984-06-22 |
1987-03-24 |
Abbott Laboratories |
Renin inhibiting compounds
|
US4880781A
(en)
*
|
1984-08-06 |
1989-11-14 |
The Upjohn Company |
Renin inhibitory peptides containing an N-alkyl-histidine moiety
|
DK356085A
(da)
*
|
1984-08-06 |
1986-02-07 |
Upjohn Co |
Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
|
DE3438545A1
(de)
*
|
1984-10-20 |
1986-04-24 |
Merck Patent Gmbh, 6100 Darmstadt |
Peptide
|
US4616088A
(en)
*
|
1984-10-29 |
1986-10-07 |
E. R. Squibb & Sons, Inc. |
Amino acid ester and amide renin inhibitor
|
US4727060A
(en)
*
|
1984-11-13 |
1988-02-23 |
Ciba-Geigy Corporation |
Novel 5-amino-4-hydroxyvaleryl derivatives
|
DE3512128A1
(de)
|
1985-04-03 |
1986-10-09 |
Merck Patent Gmbh, 6100 Darmstadt |
Peptide
|
EP0218688B1
(en)
|
1985-04-19 |
1990-09-12 |
The Upjohn Company |
Dihalo-statine substituted renin inhibitors
|
US4882420A
(en)
*
|
1985-04-19 |
1989-11-21 |
The Upjohn Company |
Dihalo-statine substituted renin inhibitors
|
US4826815A
(en)
*
|
1985-05-17 |
1989-05-02 |
Abbott Laboratories |
Renin inhibiting compounds
|
US4665055A
(en)
*
|
1985-06-17 |
1987-05-12 |
Merck & Co., Inc. |
Peptide renin inhibitors
|
US4777286A
(en)
*
|
1985-06-18 |
1988-10-11 |
The Upjohn Company |
Certain aryl or hetero-hydroxamic acid esters useful as renin inhibitors
|
US4729985A
(en)
*
|
1985-08-09 |
1988-03-08 |
Pfizer Inc. |
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
|
US4992562A
(en)
*
|
1985-08-09 |
1991-02-12 |
Pfizer Inc. |
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
|
US4906613A
(en)
*
|
1985-11-05 |
1990-03-06 |
Schering Corporation |
Antiglaucoma compositions and methods
|
US4894437A
(en)
*
|
1985-11-15 |
1990-01-16 |
The Upjohn Company |
Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
|
DE3540495A1
(de)
*
|
1985-11-15 |
1987-05-21 |
Merck Patent Gmbh |
Aminosaeurederivate
|
EP0258289A4
(en)
*
|
1986-01-16 |
1991-01-02 |
Joseph Dellaria |
Peptide analogs
|
FI870474A
(fi)
*
|
1986-02-07 |
1987-08-08 |
Ciba Geigy Ag |
Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat.
|
CA1309555C
(en)
*
|
1986-02-27 |
1992-10-27 |
Suvit Thaisrivongs |
Inhibiting peptides having a dihydroxyethylene isostere transitionstate insert
|
US4705846A
(en)
*
|
1986-03-27 |
1987-11-10 |
The Upjohn Company |
Novel renin inhibiting peptides having a gamma lactam pseudo dipeptide insert
|
US4743584A
(en)
*
|
1986-10-07 |
1988-05-10 |
Merck & Co., Inc. |
C-terminal amide cyclic renin inhibitors containing peptide isosteres
|
EP0264106B1
(en)
*
|
1986-10-14 |
1994-03-16 |
Banyu Pharmaceutical Co., Ltd. |
5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use
|
US4743585A
(en)
*
|
1986-11-21 |
1988-05-10 |
Warner-Lambert Company |
Renin inhibitors
|
US4758584A
(en)
*
|
1987-02-05 |
1988-07-19 |
Ciba-Geigy Corporation |
Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
|
US5162497A
(en)
*
|
1987-09-24 |
1992-11-10 |
The Administrators Of The Tulane Educational Fund |
Bradykinin analogs with non-peptide bond
|
EP0326364B1
(en)
*
|
1988-01-26 |
1994-06-22 |
Sankyo Company Limited |
Renin inhibitory oligopeptides, their preparation and use
|
WO1989009230A1
(en)
*
|
1988-03-25 |
1989-10-05 |
Administrators Of The Tulane Educational Fund |
Therapeutic peptides
|
IL90872A0
(en)
*
|
1988-07-08 |
1990-02-09 |
Smithkline Beckman Corp |
Retroviral protease binding peptides
|
US5688770A
(en)
*
|
1989-12-14 |
1997-11-18 |
Schering Corporation |
Antiglaucoma compositions and methods
|
US5869615A
(en)
*
|
1994-01-03 |
1999-02-09 |
Washington University |
Modified complement proteases
|
US5574017A
(en)
*
|
1994-07-05 |
1996-11-12 |
Gutheil; William G. |
Antibacterial agents
|
US6239273B1
(en)
|
1995-02-27 |
2001-05-29 |
Affymetrix, Inc. |
Printing molecular library arrays
|
US6046169A
(en)
*
|
1995-06-07 |
2000-04-04 |
Cor Therapeutics, Inc. |
Inhibitors of factor XA
|
US6022861A
(en)
*
|
1995-06-07 |
2000-02-08 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
US5721214A
(en)
*
|
1995-06-07 |
1998-02-24 |
Cor Therapeutics, Inc. |
Inhibitors of factor Xa
|
CA2223449C
(en)
|
1995-06-07 |
2008-10-07 |
Glaxo Group Limited |
Peptides and compounds that bind to the thrombopoietin receptor
|
US5919765A
(en)
*
|
1995-06-07 |
1999-07-06 |
Cor Therapeutics, Inc. |
Inhibitors of factor XA
|
US6069130A
(en)
*
|
1995-06-07 |
2000-05-30 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
FR2735983B1
(fr)
|
1995-06-29 |
1997-12-05 |
Centre Nat Rech Scient |
Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
|
US5864018A
(en)
*
|
1996-04-16 |
1999-01-26 |
Schering Aktiengesellschaft |
Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
|
US6245743B1
(en)
|
1996-06-05 |
2001-06-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor Xa
|
US7091311B2
(en)
|
1996-06-07 |
2006-08-15 |
Smithkline Beecham Corporation |
Peptides and compounds that bind to a receptor
|
US6265535B1
(en)
|
1997-05-30 |
2001-07-24 |
The Trustees Of The University Of Pennsylvania |
Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
|
US5972894A
(en)
*
|
1997-08-07 |
1999-10-26 |
Cytran, Inc. |
Peptides having potassium channel opener activity
|
US6984719B1
(en)
|
1998-09-17 |
2006-01-10 |
Hospital Sainte-Justine |
Peptide antagonists of prostaglandin F2α receptor
|
CA2697598A1
(en)
|
1999-01-12 |
2000-07-20 |
Cambridge Enterprise Limited |
Compounds and methods to inhibit or augment an inflammatory response
|
US6673771B1
(en)
|
1999-07-28 |
2004-01-06 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting osteoclast activity
|
US6682739B1
(en)
|
1999-07-28 |
2004-01-27 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting osteoclastogenesis
|
US7041465B1
(en)
|
1999-08-11 |
2006-05-09 |
Washington University |
Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
|
PT1210428E
(pt)
|
1999-08-23 |
2015-07-21 |
Genetics Inst Llc |
Pd-1, um recetor para b7-4 e suas utilizações
|
US6864355B1
(en)
|
2000-05-02 |
2005-03-08 |
Yale University |
Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
|
US7109299B1
(en)
|
1999-12-16 |
2006-09-19 |
Affymax, Inc. |
Peptides and compounds that bind to the IL-5 receptor
|
US6407211B1
(en)
|
1999-12-17 |
2002-06-18 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides
|
US6664230B1
(en)
|
2000-08-24 |
2003-12-16 |
The Regents Of The University Of California |
Orally administered peptides to ameliorate atherosclerosis
|
WO2002079499A1
(en)
|
2001-04-02 |
2002-10-10 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
ATE469167T1
(de)
|
2002-02-06 |
2010-06-15 |
Vicor Technologies Inc |
Anti-infarkt-moleküle
|
US7521530B2
(en)
|
2002-06-11 |
2009-04-21 |
Universite De Montreal |
Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
|
US20050265992A1
(en)
|
2003-01-03 |
2005-12-01 |
The Research Foundation Of State University Of New York |
F11 receptor (F11R) antagonists as therapeutic agents
|
US8557957B2
(en)
|
2003-01-03 |
2013-10-15 |
Elizabeth Kornecki |
Methods of treating disorders by administration of F11 receptor antagonists
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
EP1635858A4
(en)
|
2003-05-29 |
2009-08-26 |
Scripps Research Inst |
TARGETED RELEASE ON CELLS EXPRESSING LEGUMINUM
|
US20060035242A1
(en)
|
2004-08-13 |
2006-02-16 |
Michelitsch Melissa D |
Prion-specific peptide reagents
|
ZA200604869B
(en)
|
2003-12-04 |
2007-11-28 |
Univ Utah Res Found |
Modified macromolecules and methods of making and using thereof
|
US20100330143A1
(en)
|
2003-12-04 |
2010-12-30 |
University Of Utah Research Foundation |
Modified macromolecules and methods of making and using thereof
|
JP2007526000A
(ja)
|
2004-03-04 |
2007-09-13 |
バンダービルト ユニバーシティ |
サイトカイン誘導性シグナル伝達を阻害する細胞透過性socsポリペプチド
|
US20080269116A1
(en)
|
2004-05-11 |
2008-10-30 |
Taub Dennis D |
Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin
|
WO2005113582A1
(en)
*
|
2004-05-22 |
2005-12-01 |
Boehringer Ingelheim International Gmbh |
Substituted ethane-1,2-diamines for the treatment of alzheimer's disease
|
EP1827480B1
(en)
|
2004-12-21 |
2016-11-09 |
MUSC Foundation For Research Development |
Compositions and methods for promoting wound healing and tissue regeneration
|
US8158586B2
(en)
|
2005-04-11 |
2012-04-17 |
Pharmagap Inc. |
Inhibitors of protein kinases and uses thereof
|
EA012440B1
(ru)
|
2005-04-29 |
2009-10-30 |
Зе Риджентс Оф Зи Юнивесити Оф Кэлифонье |
Пептид, композиция на его основе для лечения патологий, связанных c воспалительными процессами
|
EP2371843B1
(en)
|
2005-05-19 |
2014-09-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
|
CA2611324C
(en)
|
2005-06-07 |
2017-02-14 |
Ocean Nutrition Canada Limited |
Eukaryotic microorganisms for producing lipids and antioxidants
|
EP2439268B1
(en)
|
2005-06-16 |
2015-11-04 |
DSM Nutritional Products AG |
Immobilized enzymes and methods of using thereof
|
EP1922328A4
(en)
|
2005-08-05 |
2010-03-10 |
Pharmagap Inc |
PEPTIDES TARGETED ON C PROTEIN KINASE ISOFORMS AND USE THEREOF
|
PT2371855E
(pt)
|
2005-08-05 |
2015-11-03 |
Araim Pharmaceuticals Inc |
Péptidos protetores de tecidos e suas utilizações
|
US8652504B2
(en)
|
2005-09-22 |
2014-02-18 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
CA2623198C
(en)
|
2005-09-22 |
2014-08-05 |
Medivas, Llc |
Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
CN101351554B
(zh)
|
2005-10-04 |
2016-05-18 |
索利金尼克斯公司 |
包括通过调节先天免疫治疗和预防感染在内的治疗和预防免疫相关疾病的新型肽
|
EP2189522A1
(en)
|
2005-10-14 |
2010-05-26 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
EA014900B1
(ru)
|
2005-11-07 |
2011-02-28 |
Зе Скрипс Ресеч Инститьют |
Композиции и способы контроля специфичности передачи сигналов, опосредуемой тканевым фактором
|
WO2007120265A2
(en)
|
2005-11-14 |
2007-10-25 |
Applera Corporation |
Coded molecules for detecting target analytes
|
US20090016988A1
(en)
|
2005-11-21 |
2009-01-15 |
Buckley J Thomas |
Modified Pore-Forming Protein Toxins and Use Thereof
|
CN102898519B
(zh)
|
2005-11-30 |
2015-10-28 |
Abbvie公司 |
抗淀粉样β蛋白的单克隆抗体及其用途
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
DK1976985T3
(da)
|
2005-12-29 |
2013-10-21 |
Univ California |
Fremgangsmåder og præparater relateret til mutant Kunitz-domæne I af TFPI-2
|
US8815804B2
(en)
|
2006-02-06 |
2014-08-26 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to targeting tumors and wounds
|
AU2007284801A1
(en)
|
2006-08-08 |
2008-02-21 |
The Regents Of The University Of Californina |
Salicylanilides enhance oral delivery of therapeutic peptides
|
US8865398B2
(en)
|
2006-09-01 |
2014-10-21 |
Abbott Laboratories |
Combination hepatitis C virus antigen and antibody detection method
|
EP3034083B1
(en)
|
2006-09-21 |
2020-12-09 |
University of Rochester |
Antisense oligonucleotides for use in treating myotonic dystrophy
|
EP2104516B1
(en)
|
2006-11-01 |
2015-01-07 |
University of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
US8637459B2
(en)
|
2006-11-08 |
2014-01-28 |
Emory University |
Enhancing a population of insulin releasing cells using GFR-A1 agonists
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
US8188220B2
(en)
|
2006-12-06 |
2012-05-29 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to targeting wounds, regenerating tissue, and tumors
|
WO2008085794A2
(en)
|
2007-01-03 |
2008-07-17 |
Burnham Institute For Medical Research |
Methods and compositions related to clot binding compounds
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
EP2596799B1
(en)
|
2007-02-08 |
2016-11-23 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
US8097588B2
(en)
|
2007-02-08 |
2012-01-17 |
Sanford-Burnham Medical Research Institute |
Trophinin-binding peptides and uses thereof
|
US8685666B2
(en)
|
2007-02-16 |
2014-04-01 |
The Board Of Trustees Of Southern Illinois University |
ARL-1 specific antibodies and uses thereof
|
US8114606B2
(en)
|
2007-02-16 |
2012-02-14 |
The Board Of Trustees Of Southern Illinois University |
ARL-1 specific antibodies
|
US20100311767A1
(en)
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
WO2009023306A2
(en)
|
2007-05-09 |
2009-02-19 |
Burnham Institute For Medical Research |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
WO2010070380A2
(en)
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
WO2009094172A2
(en)
|
2008-01-22 |
2009-07-30 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
WO2009105671A2
(en)
|
2008-02-21 |
2009-08-27 |
Burnham Institute For Medical Research |
Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications
|
US8841440B2
(en)
|
2008-04-01 |
2014-09-23 |
Cornell University |
Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
|
AU2009256202B2
(en)
|
2008-06-04 |
2014-07-03 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for the production of IPS cells using non-viral approach
|
WO2009158238A2
(en)
|
2008-06-16 |
2009-12-30 |
University Of Rochester |
Fibroblast growth factor (fgf) analogs and uses thereof
|
CA2734389A1
(en)
|
2008-08-15 |
2010-02-18 |
Vincent J. Hearing |
S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma
|
WO2010078325A2
(en)
|
2008-12-29 |
2010-07-08 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides for reducing or preventing restenosis
|
HUE033661T2
(en)
|
2009-02-16 |
2017-12-28 |
Cerenis Therapeutics Holding Sa |
Apolipoprotein A-1 mimetics
|
CA2952805C
(en)
|
2009-06-05 |
2021-06-01 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematopoietic cells
|
EP2445536B1
(en)
|
2009-06-22 |
2016-06-08 |
Burnham Institute for Medical Research |
Methods and compositions using peptides and proteins with c-terminal elements
|
US20120108514A1
(en)
|
2009-07-09 |
2012-05-03 |
University Of Iowa Research Foundation |
Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
|
US8409603B2
(en)
|
2009-10-01 |
2013-04-02 |
University Of South Carolina |
Compositions and methods for tissue engineering, tissue regeneration and wound healing
|
EP2496947A1
(en)
|
2009-11-04 |
2012-09-12 |
Novartis AG |
Positively charged species as binding reagents in the separation of protein aggregates from monomers
|
WO2011060233A1
(en)
|
2009-11-11 |
2011-05-19 |
The Trustees Of The University Of Pennsylvania |
Anti-tem1 antibodies and uses thereof
|
CA3061784C
(en)
|
2009-11-13 |
2023-09-26 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
CA2784145A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding compounds
|
IT1397901B1
(it)
|
2010-01-26 |
2013-02-04 |
Consiglio Nazionale Ricerche |
Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico.
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
NZ602634A
(en)
|
2010-03-26 |
2015-06-26 |
Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
US20110262347A1
(en)
|
2010-04-08 |
2011-10-27 |
The Salk Institute For Biological Studies |
Methods and compositions for enhanced delivery of compounds
|
EP2558494B1
(en)
|
2010-04-15 |
2018-05-23 |
AbbVie Inc. |
Amyloid-beta binding proteins
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
EP2691105B1
(en)
|
2011-03-28 |
2018-07-11 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
EP2715291A4
(en)
|
2011-05-31 |
2015-10-21 |
Airware Inc |
NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR)
|
US20130156803A1
(en)
|
2011-06-04 |
2013-06-20 |
Rochester General Hospital Research Institute |
Compositions and methods related to p6
|
WO2013010045A1
(en)
|
2011-07-12 |
2013-01-17 |
Biotime Inc. |
Novel methods and formulations for orthopedic cell therapy
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
US9102707B2
(en)
|
2011-08-30 |
2015-08-11 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides
|
WO2013103896A1
(en)
|
2012-01-06 |
2013-07-11 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
ES2819825T3
(es)
|
2012-01-26 |
2021-04-19 |
Soares Christopher J |
Antagonistas peptídicos de la familia calcitonina CGRP de hormonas peptídicas y su uso
|
WO2013130808A1
(en)
|
2012-02-29 |
2013-09-06 |
D.E. Shaw Research, Llc |
Methods for screening voltage gated proteins
|
WO2013154771A1
(en)
|
2012-04-12 |
2013-10-17 |
Georgia Regents University |
Redox-resistant nitric oxide synthase
|
WO2013162748A1
(en)
|
2012-04-27 |
2013-10-31 |
The Trustees Of The University Of Pennsylvania |
Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
EP3613765A1
(en)
|
2012-08-03 |
2020-02-26 |
Dana-Farber Cancer Institute, Inc. |
Antibody against repulsive guidance molecule b (rgmb)
|
EP2892558B1
(en)
|
2012-09-07 |
2019-04-10 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
JP6570511B2
(ja)
|
2013-03-14 |
2019-09-04 |
ユーエイビー リサーチ ファンデーション |
アポリポタンパク質模倣体及びその使用
|
WO2014201118A2
(en)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
AU2014296288B2
(en)
|
2013-07-31 |
2020-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating thermogenesis using PTH-related and EGF-related molecules
|
EP3757130A1
(en)
|
2013-09-26 |
2020-12-30 |
Costim Pharmaceuticals Inc. |
Methods for treating hematologic cancers
|
JP6590810B2
(ja)
|
2013-12-24 |
2019-10-16 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体および断片
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3094736A4
(en)
|
2014-01-14 |
2017-10-25 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
SI3154594T1
(sl)
|
2014-06-13 |
2023-10-30 |
Bach Biosciences, Llc |
FAP-aktivirana terapevtska sredstva in z njimi povezane uporabe
|
JP7081923B2
(ja)
|
2014-07-31 |
2022-06-07 |
ユーエイビー リサーチ ファンデーション |
アポe模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
|
CN106794217A
(zh)
|
2014-08-06 |
2017-05-31 |
血管生物科学 |
包含对患病组织具有选择性的药效团的组合物及其制备方法
|
US10189878B2
(en)
|
2014-09-24 |
2019-01-29 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
MX2017007136A
(es)
|
2014-12-05 |
2017-12-04 |
Immunext Inc |
Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
|
WO2016094273A1
(en)
|
2014-12-08 |
2016-06-16 |
Dana-Farber Cancer Institute, Inc. |
Methods for upregulating immune responses using combinations of anti-rgmb and anti-pd-1 agents
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
US10765754B2
(en)
|
2015-08-28 |
2020-09-08 |
Navigen, Inc. |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
WO2017066561A2
(en)
|
2015-10-16 |
2017-04-20 |
President And Fellows Of Harvard College |
Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
|
WO2017083700A1
(en)
|
2015-11-13 |
2017-05-18 |
The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Ligand-guided phagocytosis based therapy for treatment of alzheimer's disease and other neurodegenerative diseases
|
TW202216201A
(zh)
|
2016-02-12 |
2022-05-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
RU2021111187A
(ru)
|
2016-04-15 |
2021-04-29 |
Янссен Фармасьютикалз, Инк. |
Антитела против человеческого vista и их применение
|
CA3035561A1
(en)
|
2016-09-02 |
2018-03-08 |
Christopher J. Soares |
Use of cgrp receptor antagonists in neuroprotection and neurological disorders
|
EP4372002A2
(en)
|
2016-09-14 |
2024-05-22 |
The Trustees Of The University Of Pennsylvania |
Proximity-based sortase-mediated protein purification and ligation
|
US11072642B2
(en)
|
2016-11-09 |
2021-07-27 |
Mayo Foundation For Medical Education And Research |
MANP analogues
|
AR111842A1
(es)
|
2017-06-02 |
2019-08-21 |
Amgen Inc |
Antagonistas de péptido pac1
|
CN112513235B
(zh)
|
2018-06-05 |
2023-12-01 |
帝斯曼知识产权资产管理有限公司 |
用于生产甘油二酯的方法
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|